Screener
AbbVie ABBV EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from AbbVie’s reported figures.
The source filing: AbbVie’s 10-Q, filed May 8, 2026. Open the filing →
- Filed
- May 8, 2026, 12:28 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001551152-26-000017
FAQ
- What is AbbVie's EBITDA?
- AbbVie (ABBV) reported EBITDA of $5.93B in Q1 2026.
- How has AbbVie's EBITDA changed year-over-year?
- AbbVie's EBITDA increased by 2.7% year-over-year, from $5.77B to $5.93B.
- What is the long-term trend for AbbVie's EBITDA?
- Over 3 years (2021 to 2025), AbbVie's EBITDA has grown at a -4.2% compound annual growth rate (CAGR), from $26.44B to $23.28B.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about AbbVie's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude